Cronos Group Inc. Common Share (CRON)

FairStock Score: 49/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I view Cronos as a small, no-debt cannabinoid company with improving top-line momentum but a thin competitive moat. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $53.0M and net income was $32.1M, or diluted EPS of $0.09. That compares with fiscal Q2 2025, the quarter ended 2025-06-30, when revenue was $33.5M and net loss was $39.7M. The swing is real, but annual results are uneven: FY2025, ended 2025-12-31, had revenue of $146.6M and a net loss of $9.4M, or diluted EPS of -$0.02, after FY2024 produced $117.6M of revenue and $41.1M of net income, or diluted EPS of $0.11. FairStock classifies it as a TURNAROUND—Loss in the latest year after earlier profits. Financial health looks conservative: D/E is 0.00, Altman Z-Score is 12.85, and trailing free cash flow is $49.4M, a 4.2% FCF yield. But ROCE is -0.10%, and EV/EBITDA is 79.11, so operating returns are weak. At the close on 2026-10-13, the $3.20 price gives a FairStock P/B of 1.11, P/E of 16.84, Graham Number of $3.51, and margin of safety of 8.83%. Piotroski F-Score is 7/9, and the FairStock Score is 49/100. Growth from FY2023 revenue of $87.2M to FY2025 revenue of $146.6M is encouraging, and brands like Spinach and Lord Jones offer some shelf presence, but cannabis remains regulated and competitive. I would want durable profits and positive returns on capital before calling this a high-quality compounder.

In plain English: Cronos Group is a cannabis company that sells things like dried flower, pre-rolls, oils, vaporizers, edibles and tinctures in Canada, Israel and other markets. Its latest quarter showed a profit and rising sales, but the last full year was a loss after an earlier profit, so results are uneven. At $3.20 a share, the price looks roughly fair to slightly cheap compared with its accounting value and a simple value estimate, but not a clear bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer